Dr. Shaw has over 10 years’ experience in gene therapy clinical trials. She received her PhD in Microbiology from the University of Alabama Birmingham where she studied the foamy virus envelope protein. She performed postdoctoral work in the lab of Donald Kohn at Children’s Hospital Los Angeles where she engineered lentivirus vectors. In 2009, she moved to the University of California Los Angeles and managed several early phase gene transfer clinical trials for severe combined immunodeficiency (SCID), including regulatory and cell manufacturing activities.
Dr. Shaw is currently the Technical Director of the Novel Cell Therapy Laboratory, Cell Manipulation Core Facility at Dana-Farber Cancer Center. The Novel Cell Therapy Lab develops and manufactures cellular products that are more than minimally manipulated and regulated under Investigative New Drug Applications.

Regulator at Paul-Ehrlich-Institut, Germany
Co-opted member of CHMP, EMA
Member of CAT, EMA
Paediatrician